Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
04/2014
04/10/2014US20140099254 Combination therapy for inducing immune response to disease
04/09/2014EP2716757A1 Mutant replicon derived from genome of hepatitis c virus j6cf strain
04/09/2014EP2716752A1 Canine influenza recombinant virus, preparation method therefor and application thereof
04/09/2014EP2716658A2 Antibodies and methods for making and using them
04/09/2014EP2716657A2 Antibodies and methods for making and using them
04/09/2014EP2716656A1 Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof
04/09/2014EP2716653A1 Truncated human papillomavirus type 33 protein l1
04/09/2014EP2716301A2 Antibodies against ERBB3 and uses thereof
04/09/2014EP2715364A1 Method for predicting the risk of developing a colonic neoplasia
04/09/2014EP2715350A2 Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
04/09/2014EP2714911A2 Immunogenic composition
04/09/2014EP2714910A1 Immunogenic composition
04/09/2014EP2714908A1 Immunostimulatory oligodeoxynucleotides
04/09/2014EP2714907A1 Immunostimulatory oligodeoxynucleotides
04/09/2014EP2714741A2 Anti-kir antibodies for the treatment of inflammatory disorders
04/09/2014EP2714740A1 Neutralizing prolactin receptor antibody mat3 and its therapeutic use
04/09/2014EP2714722A1 Genetic vaccines against hendra virus and nipah virus
04/09/2014EP2714716A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
04/09/2014EP2714198A1 Il-21 epitope and il-21 ligands
04/09/2014EP2714084A1 Fc RECEPTOR BINDING PROTEINS
04/09/2014EP2714083A1 Rationally-designed anti-mullerian inhibiting substance type ii receptor antibodies
04/09/2014EP2714082A1 Compositions and methods for treating pain
04/09/2014EP2714081A2 Methods, compositions, and kits for the treatment of cancer
04/09/2014EP2714080A1 Methods of treating systemic lupus erythematosus, scleroderma, and myositis with an antibody against interferon-alpha
04/09/2014EP2714079A2 Deimmunized serum-binding domains and their use for extending serum half-life
04/09/2014EP2714078A1 Agents for treating tumours
04/09/2014EP2714077A1 Needle-free administration of prrsv vaccines
04/09/2014EP2714076A1 Inactivated dengue virus vaccine
04/09/2014EP2714075A1 Blood stage malaria vaccine
04/09/2014EP2714074A2 Anti-emr1 antibodies
04/09/2014EP2714073A1 In situ antigen-generating cancer vaccine
04/09/2014EP2714072A1 Modulated immunodominance therapy
04/09/2014EP2714071A2 Individualized vaccines for cancer
04/09/2014EP2714048A1 SUBSTITUTED 2-BENZYLIDENE-2H-BENZO[b][1,4]THIAZIN-3(4H)-ONES, DERIVATIVES THEREOF, AND THERAPEUTIC USES THEREOF
04/09/2014EP2714031A1 A synergistic pharmaceutical combination for the treatment of squamous cell carcinoma of head and neck
04/09/2014EP2650362A9 Novel vaccines against the a/h1n1 pandemic flu virus
04/09/2014CN203525015U Novel vaccine preparing equipment
04/09/2014CN103717742A Immunogenic composition
04/09/2014CN103717740A Pharmaceutical composition for treatment and/or prophylaxis of cancer
04/09/2014CN103717739A Pharmaceutical composition for treatment and/or prophylaxis of cancer
04/09/2014CN103717738A Drug composition for cancer treatment and/or prevention
04/09/2014CN103717737A Cancer treatment and/or prevention drug composition
04/09/2014CN103717619A Anti-kir antibodies for the treatment of inflammatory disorders
04/09/2014CN103717618A Amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides comprising the same
04/09/2014CN103717613A PRAME purification
04/09/2014CN103717263A Antibodies that bind to OX40 and their uses
04/09/2014CN103717240A Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy
04/09/2014CN103717238A Pharmaceutical composition for treatment and/or prevention of pancreatic cancer
04/09/2014CN103717237A Stabilized formulations containing anti-pcsk9 antibodies
04/09/2014CN103717236A Anti-CD22 antigen binding molecules to treat lung cancer and prostate cancer
04/09/2014CN103717235A Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators
04/09/2014CN103717234A Methods of treating and preventing staphylococcus aureus infections and associated conditions
04/09/2014CN103717233A Immunogenic composition for immune system modulation and use thereof, method for treating and preventing diseases, method for inducing cell regeneration and method for restoring immune response
04/09/2014CN103710384A Picornaviridae recombinant vector, virus like particle, and preparation method and use of virus like particle
04/09/2014CN103710314A Avian Encephalomyelitis virus attenuated vaccine strain
04/09/2014CN103710313A Newcastle disease virus strain H12 and application thereof to preparation of Newcastle disease attenuated live vaccine
04/09/2014CN103709252A Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same
04/09/2014CN103709251A Human anti-CD26 antibody and applications thereof
04/09/2014CN103709250A Human monoclonal antibodies against CD20
04/09/2014CN103709249A Antibodies and methods for making and using them
04/09/2014CN103709247A Divalent egg yolk antibodies of type I and novel duck hepatitis as well as preparation method and application thereof
04/09/2014CN103705935A Heat-proof freeze-dried protective agent and preparation method and application thereof
04/09/2014CN103705930A Method and formulation for reducing aggregation of a macromolecule under physiological conditions
04/09/2014CN103705921A Methods for treating conditions associated with MASP-2 dependent complement activation
04/09/2014CN103705920A Cytoplasmic polyadenylation element-binding protein 4 vaccine, and preparation and application thereof
04/09/2014CN103705919A Vaccine composition containing synthetic adjuvant
04/09/2014CN103705918A Porcine epidemic diarrhea virus resistant hyper-immune serum and preparation method thereof
04/09/2014CN103705917A M2e synthetic peptide swine influenza virus general vaccine and application
04/09/2014CN103705916A Vaccine of encephalomyelitis of poultry
04/09/2014CN103705915A Rhamnose modified tumor whole-cell vaccine
04/09/2014CN103705914A Staphylococcus aureus vaccine and preparation method thereof
04/09/2014CN103143008B Duck tembusu virus living vaccine and preparation method thereof
04/09/2014CN103045614B Mutant phage E gene, punching plasmid vector containing gene and application thereof in preparation of vaccine
04/09/2014CN103007271B Chicken subunit four-combination vaccine and preparation and application thereof
04/09/2014CN103007261B Riemerella anatipestifer (RA) and application thereof
04/09/2014CN102973930B Chicken subunit bivalent vaccine, as well as preparation and application thereof
04/09/2014CN102875657B Method for preparing telomerase polypeptide vaccine
04/09/2014CN102827289B Porcine circovirus type 2 Cap protein and thymosin alpha1 fusion protein and application
04/09/2014CN102824645B Gosling plague egg yolk antibody freeze-drying protective additive
04/09/2014CN102743745B Controlled-release hepatoma cell vaccine depending on granulocyte-macrophage colony-stimulating factor (GM-CSF) wrapped by nanoparticles
04/09/2014CN102367277B Polymer conjugates of mutated neublastin
04/09/2014CN102286099B Human cytomegalovirus immunoglobulin for intravenous injection and preparation method thereof
04/09/2014CN102046657B Antibodies directed to angiopoietin-1 and angiopoietin-2 and use thereof
04/09/2014CN101972475B Bacterial polysaccharide-protein conjugate vaccine and preparation method thereof
04/09/2014CN101528259B Human antibodies that bind cxcr4 and uses thereof
04/09/2014CN101511870B Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
04/09/2014CN101325966B Functional influenza virus like particles (VLP)
04/08/2014US8691961 Flavivirus reporter virus and methods of making and using the same
04/08/2014US8691955 Use of α1G subunit of T-type calcium channel as diagnostic marker for pregnancy in cattle
04/08/2014US8691945 Antimicrobial peptides
04/08/2014US8691769 Treatment of sinusitis related chronic facial pain and headache with botulinum toxin injections
04/08/2014US8691752 Protein product for treatment of infectious diseases and related inflammatory processes
04/08/2014US8691563 IDNA vaccines and methods for using the same
04/08/2014US8691550 Vaccines against japanese encephalitis virus and west nile virus
04/08/2014US8691545 Bone semi-permeable device
04/08/2014US8691502 T-cell vaccination with viral vectors via mechanical epidermal disruption
04/08/2014US8691243 Protein-based Streptococcus pneumoniae vaccine
04/08/2014US8691242 Staphylococcus aureus DIV1B for use as vaccine
04/08/2014US8691241 Reoviruses having modified sequences
04/08/2014US8691239 Influenza hemagglutinin and neuraminidase variants
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 1823